These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36717525)

  • 1. Characteristics of familial pancreatic cancer families with additional colorectal carcinoma.
    Lehman B; Matthäi E; Gercke N; Denzer UW; Figiel J; Hess T; Slater EP; Bartsch DK
    Fam Cancer; 2023 Jul; 22(3):323-330. PubMed ID: 36717525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
    Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A
    EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in Japanese familial pancreatic cancer patients.
    Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T
    Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A germline mutations in familial pancreatic cancer.
    Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H
    Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
    Chaffee KG; Oberg AL; McWilliams RR; Majithia N; Allen BA; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Petersen GM
    Genet Med; 2018 Jan; 20(1):119-127. PubMed ID: 28726808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial pancreatic cancer--status quo.
    Fendrich V; Langer P; Bartsch DK
    Int J Colorectal Dis; 2014 Feb; 29(2):139-45. PubMed ID: 23948969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
    Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK
    Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
    Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
    Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Scand J Gastroenterol; 2021 Aug; 56(8):965-971. PubMed ID: 34165379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The German National Case Collection for Familial Pancreatic Carcinoma (FaPaCa)—Knowledge Gained in 20 Years.
    Bartsch DK; Matthäi E; Mintziras I; Bauer C; Figiel J; Sina-Boemers M; Gress TM; Langer P; Slater EP
    Dtsch Arztebl Int; 2021 Mar; 118(10):163-8. PubMed ID: 33531114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer.
    Slater EP; Wilke LM; Böhm LB; Strauch K; Lutz M; Gercke N; Matthäi E; Hemminki K; Försti A; Schlesner M; Paramasivam N; Bartsch DK
    J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PALB2 mutations in European familial pancreatic cancer families.
    Slater EP; Langer P; Niemczyk E; Strauch K; Butler J; Habbe N; Neoptolemos JP; Greenhalf W; Bartsch DK
    Clin Genet; 2010 Nov; 78(5):490-4. PubMed ID: 20412113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.
    Schneider R; Slater EP; Sina M; Habbe N; Fendrich V; Matthäi E; Langer P; Bartsch DK
    Fam Cancer; 2011 Jun; 10(2):323-30. PubMed ID: 21207249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial pancreatic cancer--current knowledge.
    Bartsch DK; Gress TM; Langer P
    Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):445-53. PubMed ID: 22664588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
    Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
    Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.